亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

New Targets for Chagas Disease Diagnosis and Treatment

*Abstract

Background

Blood feeding insects are of great concern not only because of their annoying and often painful bites, but more importantly because many can also be carriers of pathogenic organisms that seriously injure or kill humans and domestic animals. Examples of diseases caused by such pests are Lyme disease, malaria, Chagas disease, bubonic plague, Rocky Mountain fever, and many more.

Trypanosoma cruzi causes Chagas disease in humans. Acute infection can be lethal, but the disease usually evolves into a chronic stage, accompanied in 25-30% of cases by severedebilitation and ultimately death. It is estimated that 16-18 million people are infected, primarily in Central and South America, with21,000 deaths reported each year.

Historical attempts to develop vaccines for such parasitic diseases have been largely futile, and there is a critical lack of methods for diagnosis and treatment for T. cruzi in particular.Improved drugs and vaccines for the treatment and prevention of T. cruzi infection are needed, as are improved diagnostic methods.

Technology Summary

Proteomic analysis of T. cruzi has identified many new life-stage specific molecular targets suitable for use in prevention, diagnosis, and treatment of Chagas disease.

Advantages

  • Previously unknown targets that are essential for energy generation in specific life cycle stages
  • Discovery of additional stage-related T. cruzi proteins opens up new avenues for diagnosis, treatment and prevention
  • Diagnosis of T. cruzi infection through any number of stage-specific T. cruzi proteins to provide more accurate diagnosisof Chagas disease

Potential Applications

  • Vaccine development
  •  Diagnostic kits
  • Targets for drug development
  • Development of screening assays toidentify inhibitors of stage-related enzymespresent in mammalian host orinsect vectors, which could then be usedas therapeutic agents to treat T. cruziinfection
*IP Issue Date
None
*IP Type
Utility
國家
United States
申請號碼
7,780,969
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備